Site Specific Information Form Completion

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "Site Specific Information Form Completion"

Transcription

1 Site Specific Information Form Completion The IMPROVE ethics application has been received by England and Scotland ethics committees. We now need to submit a Site Specific Information form (SSI) for each site taking part in the trial. In order to complete the SSIs, each site will need to do the following: Allocate a trial coordinator to gather & collate information for the SSI The trial coordinator will need NRES or IRAS account. These are the central ethics websites. If the coordinator already has an account with NRES they do not need to set up a new account. If you don't already have an ethics account, please: o go to o o click on Enter, go to CREATE ACCOUNT at the top of the page and then follow instructions to register o When you have an NRES or IRAS account, please Trial Manager Dr Pinar Ulug at or with the address the account is registered to so the SSI may be transferred for site completion. Once the form is completed: o click on the "Navigate" button o click on the "submission" tab o click "print for submission" this will lock the form, create a site specific code and a pdf of the form which may be saved and printed o when you have printed the form please sign it and submit the original signed copy, along with the PI's 2-page summary CV to your Comprehensive Local Research Network / Research & Development department.

2 General guidance on the SSI form The Site-Specific Information Form (SSI) Form is a combined form for NHS review (for any research where the site is within the NHS) and for site-specific assessment (SSA) to support ethical review, where required. Some of the answers in the SSI Form will have appeared automatically and will be identical to the answers the Chief Investigator gave to earlier questions in Parts A and B. Question 2 Principal Investigator/ Local Collaborator The PI should also submit a summary CV with the application. It is recommended that applicants use the CV template available in IRAS or, if not, the CV should include the areas of information in this template. For example, it should give evidence of previous research in the same field of study, and other relevant experience and training. The length should be a maximum of 2 pages of A4. The CV should be signed and dated prior to submission. Local Collaborators do not need to submit a CV. Tip: It is helpful to show you have had GCP training. Question 3 Research locations The information supplied in this question should be in sufficient detail to allow the location(s) and scale of the research to be assessed. Explain which parts of the research will take place in each location, and give details of any major equipment or facilities that will be used. Question 5 Members of local research team List other members of the research team for this research at this site who will have a significant research role (e.g. other clinical investigators, trial nurses, staff who will interview participants). Include a complete list of investigators who will be accountable to the named Principal Investigator for the site. Any staff, e.g. clinical trial administrators, who will have access to participant identifiable information should be included in this section. Indicate the individual s role in the research team Do not give names of individuals whose involvement in the research is limited to carrying out their normal clinical or administrative duties. Researchers and research nurses should also submit a summary CV with the application. The CV must include the information in the recommended template CV. Tip: It is helpful to show you have had GCP training.

3 Question 6 Conflict of interest Any potential conflicts of interest should be raised here. The SSA will consider whether the issues raised pose any ethical concerns for the project. NHS R&D will consider the business implications for the NHS organisation. Question 7 Local study dates Give the proposed start date and the proposed end date of the research within the NHS organisation. You may not know these dates exactly, but a rough estimate should be supplied. Allow sufficient time in the start date for your applications to all bodies who need to approve the research. The end date is the date on which all procedures specified in the protocol are concluded. Questions 8-2 & 9-2 Local variations in study procedures The table has been populated with information from Part A, completed by the CI. Please insert details of the local members of the research team who will conduct procedures. If any variation is proposed in the study procedures to be undertaken at this site, for example related to the local standard of care, select Yes. This will allow you to make alterations to the information in the table. The review will check that any variation is permitted within the terms of the protocol and the full application submitted to the main REC. If not, the PI should advise the CI to notify the main REC and seek ethical review of a protocol amendment applicable to the site and, if appropriate, the local version of the participant information sheet. Question 10 Number of participants Give details of the planned number of participants locally. The sample for the research may include participants who are not approached but whose records or samples are to be studied. Question 11 Identifying potential participants Explain how potential participants will be identified and approached locally. Who will review registers, lists or medical records to identify participants? Question 12 Obtaining informed consent This question only applies to research where consent will be sought.

4 The review will check that the person(s) taking informed consent locally are appropriate for the task. They should be fully informed about the nature of the study. They should be aware of the process of taking consent, including any specific issues relating to consent with the potential participant population, and familiar with best practice. Any specific training received should be described. This person should have sufficient time and expertise to answer questions that might be raised by the research participants. Questions 13-2 to 4 Adults with incapacity Explain what local arrangements will be made to for adults unable to consent for themselves. Different legal arrangements apply in each of the countries in the UK. Research involving adults unable to consent for themselves For guidance on the legal and ethical implications of conducting research with adults with incapacity see Question 14 Research involving emergency treatment This question only applies in England, Wales and Northern Ireland. Explain what local arrangements will be made to for adults unable to consent for themselves where the research involves urgent treatment. Question 15 Independent contact point It is good research practice to inform potential participants where they may obtain independent information or advice about their rights as research subjects or about being involved in this particular research study. Provision for independent advice may already be included in the generic information sheet. However, if there is an appropriate local source this should be cited here and added to the information sheet locally. Members of the research team should not be named as sources of independent advice. It is not essential for the independent advisor to be a clinician. It is the role of the study doctor (or other healthcare professional on the research team) to provide clinical advice. The role of the independent advisor is to enable the participant to weigh up the decision whether or not to participate, taking into account the information provided about the study. RECs should not be cited here. It is not the role of NHS RECs to give direct advice or support to participants in this way. If there is no appropriate individual or agency, please answer No.

5 Question 16 Local version of the participant information sheet The R&D office will check that relevant site-specific information has been included in the local version to make it suitable for local participants. It is a requirement of Good Clinical Practice that participants should be able to find out more information about the proposed research should they wish to do so. Details must be included in the local version submitted for review. Participants should be informed how they may make a complaint, if necessary, about the way they have been approached or treated in the course of the research. The contact point for complaints must be included on the local version. This may be the local NHS complaints mechanism. It is important that the participant information sheet and any other correspondence should be on official headed paper. The official headed paper of the NHS organisation (e.g. a Trust or a GP practice) should be used. Electronic versions of headers may be available to coordinating offices that are assisting in preparation of study paperwork. Private (personal) headed paper is not sufficient. Question 17 Language issues The local Principal Investigator should describe here how he/she will implement those approved generic arrangements locally. Where use of interpreters is desirable, the PI should describe the proposed local arrangements for their availability. Question 18 Information for professional carers The review will check that those responsible for the professional care of a participant are told of their involvement in the research. Sufficient details should also be recorded in the patient s medical records, to ensure that the future treatment of the patient is compatible with their involvement in the study. Question 19 Facilities and staffing The review will check that the local facilities and staff are adequate for the research to be undertaken safely in relation to the procedures to be undertaken. State what arrangements have been made to deal with potential risks, to minimise harm to participants and to respond to emergencies. Question 21 Funding This question relates to the funding provided to the local site. Overall project funding should have been discussed between the Chief Investigator and the lead NHS organisation at an early stage in planning, as part of the preparation of a grant application or arrangements for funding, to ensure that local NHS costs have been adequately addressed. For multi-site studies some of the overall project funding may be allocated to collaborating centres and this is described as

6 local funding. Principal Investigators should record details of this local funding in this section. If not commercially sponsored, give details of any funding for the research at this site, e.g. NIHR, health department, charities, collaborative R&D funded by industry. Include funding to the NHS organisation and/or partner university for this research at this site. This will allow the relevant organisations to ensure appropriate allocation of funds to cover their costs. Funding may be paid to the NHS organisation or to a university account or both. Where the funding is to be paid to an organisation other than the care organisation and there will be costs incurred by the care organisation, appropriate contracts or agreements between the organisations must be in place to ensure the care organisation is able to reclaim its costs Question 23 Authorisations This section must be completed in accordance with the NHS organisation's internal guidance. The method of internal authorisation varies in NHS organisations. In some cases authorisation by, for example, line managers, support department managers or finance managers, should be obtained on the SSI Form. The NHS organisation should provide clear guidance on which individuals have authority to sign this section. Where university employers have arrangements in place with partner NHS organisations, authorisation from the university to the NHS organisation can be provided in this section. In some NHS organisations a central system may coordinate all authorisations, and signatures should not be obtained on this form. Researchers should note that where a central process is in place in the NHS organisation, attempts to obtain signatures or authorisations independently may cause delay to review and permission. Where authorisations are required on the SSI Form, all sections should be completed by the authoriser. NHS organisations should provide guidance to authorisers on the text to describe the type of authorisation and what the authorisation means. The required number of authorisation sections can be created by ticking the box for further authorisations. Once the appropriate number of authorisation pages has been created, the form should be printed off for completion by the authorisers. Examples of the type of authorisation that may be required are: clinical directors, student clinical supervisors, line managers, service managers, support department managers, pharmacy, data protection officers or finance managers, depending on the nature of the research. Managers completing this section should confirm in the text what the authorisation means, in accordance with the guidance provided by the NHS organisation Declaration Please read the bullet points carefully. By signing this, the Principal Investigator is legally agreeing to its contents.

7 Flow diagram of trial Care algorithm Patient with suspected raaa for ambulance transfer Direct to vascular centre offering 24/7 Arrival in hospital A&E or receiving unit A&E or receiving unit clinical diagnosis of raaa Randomisation (telephone/web) n=600 Immediate CT eevar strategy n=300 raaa n=15 Not raaa n=15 Normal care with open raaa n=300 raaa eevar if possible n~180 EVAR, ~105 open repair Other specialist referral laparotomy open repair n=285 Primary end point 30-day mortality Secondary endpoints: 24h, in-hospital & 1y mortality, major morbidities, reinterventions, costs, cost-effectiveness modelling

Integrated Research Application System (IRAS) Question-specific guidance. Site-specific information form (NHS sites)

Integrated Research Application System (IRAS) Question-specific guidance. Site-specific information form (NHS sites) Integrated Research Application System (IRAS) Question-specific guidance Site-specific information form (NHS sites) This version of the guidance on the Site-Specific Information Form (SSIF) applies to

More information

RESEARCH AND DEVELOPMENT GAINING NHS RESEARCH PERMISSION FROM CARDIFF AND VALE UHB - GUIDANCE FOR RESEARCHERS. Research Governance Group

RESEARCH AND DEVELOPMENT GAINING NHS RESEARCH PERMISSION FROM CARDIFF AND VALE UHB - GUIDANCE FOR RESEARCHERS. Research Governance Group RESEARCH AND DEVELOPMENT GAINING NHS RESEARCH PERMISSION FROM CARDIFF AND VALE UHB - GUIDANCE FOR RESEARCHERS Reference No: UHB 074 Version No: 5 Previous Trust / LHB Ref No: N/A Documents to read alongside

More information

An introduction to Research Management and Governance (RM&G) in the NHS

An introduction to Research Management and Governance (RM&G) in the NHS An introduction to Research Management and Governance (RM&G) in the NHS Rachel Davis Assistant RM&G Project Manager Natassia Embury R&D Facilitator 14/04/2014 Delivering clinical research to make patients,

More information

ROLES, RESPONSIBILITIES AND DELEGATION OF DUTIES IN CLINICAL TRIALS OF MEDICINAL PRODUCTS

ROLES, RESPONSIBILITIES AND DELEGATION OF DUTIES IN CLINICAL TRIALS OF MEDICINAL PRODUCTS ROLES, RESPONSIBILITIES AND DELEGATION OF DUTIES IN CLINICAL TRIALS OF MEDICINAL PRODUCTS STANDARD OPERATING PROCEDURE NO SOP 09 DATE RATIFIED 4/7/13 NEXT REVIEW DATE 4/7/14 POLICY STATEMENT/KEY OBJECTIVES:

More information

KCH Research Office. IRAS Guidance

KCH Research Office. IRAS Guidance KCH Research Office IRAS Guidance The Integrated Research Application System (IRAS) is an online tool which enables researchers to create a core data set and then to create the forms which they will need

More information

Non-commercially sponsored, NUH based single centre studies

Non-commercially sponsored, NUH based single centre studies 1. INTRODUCTION This SOP has been produced in accordance with Medicines for Human Use (Clinical Trials) Regulations 2004, amended Regulations 2006 the Research Governance Framework 2005 and Governance

More information

NHS Site Specific Information (SSI) Forms

NHS Site Specific Information (SSI) Forms Health and Care Research Wales Permissions Service NHS Site Specific Information (SSI) Forms Guidance on how to create a NHS Site Specific Information (SSI) in the Integrated Research Application System

More information

Summary of the role and operation of NHS Research Management Offices in England

Summary of the role and operation of NHS Research Management Offices in England Summary of the role and operation of NHS Research Management Offices in England The purpose of this document is to clearly explain, at the operational level, the activities undertaken by NHS R&D Offices

More information

Request for Sponsorship and HEY R&D approval for HEY-sponsored CTIMPs

Request for Sponsorship and HEY R&D approval for HEY-sponsored CTIMPs R&D Department Request for Sponsorship and HEY R&D approval for HEY-sponsored CTIMPs Hull And East Yorkshire Hospitals NHS Trust 2010 All Rights Reserved No part of this document may be reproduced, stored

More information

Application package to HRA

Application package to HRA Application package to HRA Before submitting your application, please review the information about the standards against which the HRA will review applications in HRA assessment: http://www.hra.nhs.uk/resources/hra-approval-applicant-guidance/hra-assessmentcriteria-and-standards/

More information

Proportionate Review (PR) IRAS Application & Documents. Authorisations & Signatures. Contact CBS Team

Proportionate Review (PR) IRAS Application & Documents. Authorisations & Signatures. Contact CBS Team Proportionate Review (PR) What is Proportionate Review? Is my study suitable for Proportionate Review? IRAS Application & Documents What is an IRAS application form? What documents do I need? Completing

More information

National Institute for Health Research Coordinated System for gaining NHS Permission (NIHR CSP)

National Institute for Health Research Coordinated System for gaining NHS Permission (NIHR CSP) National Institute for Health Research Coordinated System for gaining NHS Permission (NIHR CSP) Operating Manual Please check the CRN Website for the latest version. Version: 6.0 Status: Consultation in

More information

Study-wide considerations: identifies the areas of the criterion the lead reviewer should consider when conducting the review

Study-wide considerations: identifies the areas of the criterion the lead reviewer should consider when conducting the review UK STUDY-WIDE GOVERNANCE CRITERIA FOR R&D REVIEW INTRODUCTION The following document is intended to provide operational guidance to the person taking the UK lead in conducting the R&D Study-Wide review

More information

NHS and Private Interface Prescribing Guide

NHS and Private Interface Prescribing Guide NHS and Private Interface Prescribing Guide 1 Background 1.1 The following guide has been developed to assist General Practitioners (GPs) in dealing with requests to prescribe by registered patients following

More information

HRA Approval: Question and Answers

HRA Approval: Question and Answers HRA Approval: Question and Answers This document is split into sections to help you find the answer to your question more easily. As the HRA Approval Programme develops, we will update this document add

More information

Document Title: Trust Approval and Research Governance

Document Title: Trust Approval and Research Governance Document Title: Trust Approval and Research Governance Document Number: SOP034 Staff involved in development: Job titles only Document author/owner: Directorate: Department: For use by: RM&G Manager, R&D

More information

The Mental Capacity Act 2005 and research. Prof Nigel Wellman Chair Berkshire Research Ethics Committee & Oxfordshire C Research Ethics Committee

The Mental Capacity Act 2005 and research. Prof Nigel Wellman Chair Berkshire Research Ethics Committee & Oxfordshire C Research Ethics Committee The Mental Capacity Act 2005 and research Prof Nigel Wellman Chair Berkshire Research Ethics Committee & Oxfordshire C Research Ethics Committee What is the MCA about? The MCA is about people over the

More information

Implementing the Research Governance Framework Guidelines for New Researchers. Juliet MacArthur Alison Goulbourne

Implementing the Research Governance Framework Guidelines for New Researchers. Juliet MacArthur Alison Goulbourne Implementing the Research Governance Framework Guidelines for New Researchers Juliet MacArthur Alison Goulbourne March 2007 0 Note from the authors This document is designed to provide a step by step guide

More information

Trust/Host Site Approval. Presented by: Anika Kadchha Research Governance Officer

Trust/Host Site Approval. Presented by: Anika Kadchha Research Governance Officer Trust/Host Site Approval Presented by: Anika Kadchha Research Governance Officer Joint Research & Enterprise Office Training 19 th January Outline What is Research NHS Ethics (if required) Host Site Approval

More information

Guidance Document for HRA Statement of Activities for Participating NHS Organisations in England (version 4.1)

Guidance Document for HRA Statement of Activities for Participating NHS Organisations in England (version 4.1) Guidance Document for HRA Statement of Activities for Participating NHS Organisations in England (version 4.1) What is the HRA Statement of Activities? The Statement of Activities is part of the application

More information

Clinical Research Facility: Feasibility Form

Clinical Research Facility: Feasibility Form SHEFFIELD CLINICAL RESEARCH FACILITY FEASIBILITY REVIEW The Clinical Research Facility (CRF) is a resource available to all clinical researchers within Sheffield which provides a specialist environment

More information

Table of Contents 1. Contents...1

Table of Contents 1. Contents...1 Table of Contents 1. Contents...1 1.1 Introduction/Getting Started...1 1.1.1 Creating an Account...1 1.1.2 Logging In...2 1.1.3 Forgotten Password...2 1.1.4 Creating a New Project...3 1.2 My Projects...3

More information

STANDARD OPERATING PROCEDURE FOR RESEARCH. 2. Notification of Serious Breaches of Good Clinical Practice or Study Protocol

STANDARD OPERATING PROCEDURE FOR RESEARCH. 2. Notification of Serious Breaches of Good Clinical Practice or Study Protocol Basildon and Thurrock University Hospitals NHS FT Research & Development APPROVED STANDARD OPERATING PROCEDURE FOR RESEARCH 2. Notification of Serious Breaches of Good Clinical Practice or Study Protocol

More information

Title: Obtaining NHS Permission at UCLH

Title: Obtaining NHS Permission at UCLH Title: Obtaining NHS Permission at UCLH SOP Number and Version: 3, V1 Effective Date: 24/02/2015 Review Date: 24/02/2018 Please check this is the latest version of the SOP on the Joint Research Office

More information

On- going access to treatment following the completion of non commercially funded clinical trials covered by department of health guidance HSG (97) 32

On- going access to treatment following the completion of non commercially funded clinical trials covered by department of health guidance HSG (97) 32 On- going access to treatment following the completion of non commercially funded clinical trials covered by department of health guidance HSG (97) 32 SWBCCG Pol 14 Page 1 of 9 NHS Central Midlands Commissioning

More information

NAVIGATING ETHICAL APPROVAL AND ACCESS IN SOCIAL CARE RESEARCH

NAVIGATING ETHICAL APPROVAL AND ACCESS IN SOCIAL CARE RESEARCH NAVIGATING ETHICAL APPROVAL AND ACCESS IN SOCIAL CARE RESEARCH January 2014 Preamble This document has been produced by the Scottish Government, the Association of Directors of Social Work (ADSW) and the

More information

Private medical insurance claim form

Private medical insurance claim form Private medical insurance claim form *113N1A3B* Please make sure that you read the following before completing the claim form: n Confirmation of cover will be provided when we have made a decision on your

More information

Research & Development Guidance for Students

Research & Development Guidance for Students Research & Development Guidance for Students 2 Contents Introduction 3 Understanding the Research Approval Process 3 Is My Project Audit, Research or Something Else 4 What Next? 4 R&D Step by step Guide

More information

RD SOP17 Research data management and security

RD SOP17 Research data management and security RD SOP17 Research data management and security Version Number: V2 Name of originator/author: Dr Andy Mee, R&I Manager Name of responsible committee: R&I Committee Name of executive lead: Medical Director

More information

SUPPORTING INFORMATION FOR APPRAISAL AND REVALIDATION: GUIDANCE FOR SURGERY

SUPPORTING INFORMATION FOR APPRAISAL AND REVALIDATION: GUIDANCE FOR SURGERY SUPPORTING INFORMATION FOR APPRAISAL AND REVALIDATION: GUIDANCE FOR SURGERY Based on the Academy of Medical Royal Colleges and Faculties Core for all doctors. FOREWORD As part of revalidation, doctors

More information

LOUGHBOROUGH UNIVERSITY RESEARCH OFFICE STANDARD OPERATING PROCEDURE. Loughborough University (LU) Research Office

LOUGHBOROUGH UNIVERSITY RESEARCH OFFICE STANDARD OPERATING PROCEDURE. Loughborough University (LU) Research Office LOUGHBOROUGH UNIVERSITY RESEARCH OFFICE STANDARD OPERATING PROCEDURE Loughborough University (LU) Research Office SOP 1033 LU Process for Assessing Site Feasibility for NHS Research Sponsored by Loughborough

More information

Archiving of Research Documentation

Archiving of Research Documentation Suspension, Termination & Completion Standard Operating Procedure VERSION / REVISION: 2.0 EFFECTIVE DATE: 28 05 12 REVIEW DATE: 28 05 14 AUTHOR(S): CONTROLLER: APPROVED BY: Clinical Trials Manager; Recruitment

More information

Legal and governance framework

Legal and governance framework Annex A Legal and governance framework This annex is a brief guide to the legal and governance framework relevant to research in the UK. It is not intended to be a comprehensive statement of the law or

More information

Document Title: Supply of Clinical Trials Investigational Material: Dispensing, Returns and Accountability

Document Title: Supply of Clinical Trials Investigational Material: Dispensing, Returns and Accountability Document Title: Supply of Clinical Trials Investigational Material: Document Number: SOP072 Staff involved in development: Job titles only Document author/owner: Directorate: Department: For use by: RM&G

More information

Does my project require review by a Research Ethics Committee?

Does my project require review by a Research Ethics Committee? National Research Ethics Service Does my project require review by a Research Ethics Committee? This algorithm is designed to assist researchers, sponsors and R&D offices in determining whether a project

More information

A step-by-step guide to making a complaint about health and social care

A step-by-step guide to making a complaint about health and social care A step-by-step guide to making a complaint about health and social care www.healthwatchhampshire.co.uk Step by step Page 3 Are you concerned about something that is happening now? Do you need to make a

More information

gsop-32-02 - Vendor Assessment SOP page 1 of 10

gsop-32-02 - Vendor Assessment SOP page 1 of 10 gsop-32-02 - Vendor Assessment SOP page 1 of 10 Hertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust VENDOR ASSESSMENT Research & Development

More information

Attributing the costs of health & social care Research & Development Understanding AcoRD

Attributing the costs of health & social care Research & Development Understanding AcoRD Attributing the costs of health & social care Research & Development Understanding AcoRD Trudi Simmons Senior Manager Research Finance & Programmes Trudi.simmons@dh.gsi.gov.uk 1 Implementation Intoduction

More information

Dorset Research Consortium. Research Governance: A handbook for Researchers in Dorset

Dorset Research Consortium. Research Governance: A handbook for Researchers in Dorset Dorset Research Consortium Research Governance: A handbook for Researchers in Dorset DRC Version 1 dated 25 th July 2012 Research Governance: The Basics... 4 What is Research Governance?... 4 The Research

More information

September Research Ethics: Guidance for the Voluntary Sector

September Research Ethics: Guidance for the Voluntary Sector September 2012 Research Ethics: Guidance for the Voluntary Sector Research: The systematic investigation into and study of materials, sources, etc., in order to establish facts and reach new conclusions.

More information

The EFGCP Report on The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Estonia

The EFGCP Report on The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Estonia The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Estonia Question 1: What laws or regulations apply to an application for conducting a clinical

More information

Research and Development Grants Guidance for applicants

Research and Development Grants Guidance for applicants Research and Development Grants Guidance for applicants Background The promotion of resuscitation science research is a primary objective of the Resuscitation Council (UK) (RC (UK)). Applications for research

More information

Points to consider when assessing the feasibility of research

Points to consider when assessing the feasibility of research Points to consider when assessing the feasibility of research Prepared by the: Association of Medical Research Charities (AMRC) and NIHR Medicines for Children Research Network (MCRN) The Medicines for

More information

Guidance on nominating a consultee for research involving adults who lack capacity to consent

Guidance on nominating a consultee for research involving adults who lack capacity to consent Guidance on nominating a consultee for research involving adults who lack capacity to consent Issued by the Secretary of State and the Welsh Ministers in accordance with section 32(3) of the Mental Capacity

More information

CONTROLLED DOCUMENT- DO NOT COPY STANDARD OPERATING PROCEDURE. STH Investigator

CONTROLLED DOCUMENT- DO NOT COPY STANDARD OPERATING PROCEDURE. STH Investigator Research Department STANDARD OPERATING PROCEDURE STH Investigator Archiving of Essential Documentation Generated During Clinical Research SOP Number A127 Version Number V1.3 Effective Date Author Zoe Whiteley

More information

The Health Research Authority. Janet Wisely. April 2015

The Health Research Authority. Janet Wisely. April 2015 The Health Research Authority Janet Wisely April 2015 The HRA as an organisation A Non-Departmental Public Body January 2015 Public sector employees on NHS terms Volunteer members of committees A Special

More information

TRIAL MASTER FILE- SPONSORED

TRIAL MASTER FILE- SPONSORED gsop-06-04 - Management of TMF for ENHT/ WHHT Sponsored CTIMPs Page 1 of 16 Hertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust TRIAL MASTER

More information

Wales Patient Access Scheme: Process Guidance

Wales Patient Access Scheme: Process Guidance Wales Patient Access Scheme: Process Guidance July 2012 (Updated September 2014) This guidance document has been prepared by the Patient Access Scheme Wales Group, with support from the All Wales Therapeutics

More information

Attributing the costs of health and social care Research & Development (AcoRD)

Attributing the costs of health and social care Research & Development (AcoRD) Frequently Asked Questions Annex B Q1. Why have you revised the guidance on attributing Research Costs, Support Costs and Treatments Cost in the NHS? A. The definitions of Research Costs, NHS Support Costs

More information

The EFGCP Report on The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Denmark

The EFGCP Report on The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Denmark The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Denmark Question 1: What laws or regulations apply to an application for conducting a clinical

More information

D10 Referrals/notifications

D10 Referrals/notifications D10 Referrals/notifications Guideline D10.01 During the course of professional practice, the optometrist has a duty to refer the patient for appropriate ongoing clinical care and/or management whenever

More information

EU DIRECTIVE ON GOOD CLINICAL PRACTICE IN CLINICAL TRIALS DH & MHRA BRIEFING NOTE

EU DIRECTIVE ON GOOD CLINICAL PRACTICE IN CLINICAL TRIALS DH & MHRA BRIEFING NOTE EU DIRECTIVE ON GOOD CLINICAL PRACTICE IN CLINICAL TRIALS DH & MHRA BRIEFING NOTE Purpose 1. The Clinical Trials Directive 2001/20/EC heralds certain additional responsibilities for the Medicines and Healthcare

More information

Supporting information for appraisal and revalidation: guidance for General Practitioners

Supporting information for appraisal and revalidation: guidance for General Practitioners Supporting information for appraisal and revalidation: guidance for General Practitioners Based on the Academy of Medical Royal Colleges and Faculties Core for all doctors 2 Supporting information for

More information

Joint Research Office

Joint Research Office Office Location: 1 st Floor Maple House 149 Tottenham Court Road London W1T 7DN Joint Research Office Postal Address: UCL, Gower Street London WC1E 6BT Email: hameedah.bogle-dawoud@nhs.net Tel No. 020

More information

Research PET-CT scans costs attribution guidance

Research PET-CT scans costs attribution guidance 1 Research PET-CT scans costs attribution guidance Click for information on each of the topics below Does patient undergo more than one PET-CT scan? YES Each PET-CT scan must be considered separately If

More information

Research funding applications involving Cardiff & Vale UHB. Emma Lewis R&D Coordinator. Cardiff and Vale UHB Bwrdd lechyd Prifysgol Caerdydd a r Fro

Research funding applications involving Cardiff & Vale UHB. Emma Lewis R&D Coordinator. Cardiff and Vale UHB Bwrdd lechyd Prifysgol Caerdydd a r Fro Research funding applications involving Cardiff & Vale UHB Emma Lewis R&D Coordinator Objectives R&D review of grant applications Identifying resources required for your project Attributing costs using

More information

Research in the NHS: HR Good Practice Resource Pack. Frequently Asked Questions: Managing and Monitoring the Research Passport System

Research in the NHS: HR Good Practice Resource Pack. Frequently Asked Questions: Managing and Monitoring the Research Passport System Research in the NHS: HR Good Practice Resource Pack Frequently Asked Questions: Managing and Monitoring the Research Passport System Version 1.0, February 2010 MANAGING AND MONITORING THE RESEARCH PASSPORT

More information

JOINT RESEARCH AND DEVELOPMENT OFFICE. Standard Operating Procedure for Investigators and the Joint R&D Office Staff SOP 22

JOINT RESEARCH AND DEVELOPMENT OFFICE. Standard Operating Procedure for Investigators and the Joint R&D Office Staff SOP 22 JOINT RESEARCH AND DEVELOPMENT OFFICE Standard Operating Procedure for Investigators and the Joint R&D Office Staff SOP 22 Updated By Praseeda Thaikalloor Clinical trials Manager Joint R&D office for GOSH/ICH

More information

Mental Health Act. Institute of Psychiatry, Psychology & Neuroscience

Mental Health Act. Institute of Psychiatry, Psychology & Neuroscience Institute of Psychiatry, Psychology & Neuroscience South London and Maudsley NHS Foundation Trust in association with reliable and up-to-date information about psychosis for family members and friends

More information

The EFGCP Report on The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Russia

The EFGCP Report on The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Russia The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Russia Question 1: What laws or regulations apply to an application for conducting a clinical

More information

What is Clinical Audit?

What is Clinical Audit? INTRODUCTION The aim of this guide is to provide a brief summary of what clinical audit is and what it isn t. Aspects of this guide are covered in more detail in the following How To guides: How To: Choose

More information

Measures. SOP Number: UoA-NHSG-SOP-045 Version No: 1

Measures. SOP Number: UoA-NHSG-SOP-045 Version No: 1 Standard Operating Procedure: Management of Deviations, Breaches and Urgent Safety SOP Number: UoA-NHSG-SOP-045 Version No: 1 Author: Date: 27 th March 2015 (Patricia Burns, Research Governance Manager,

More information

Managing Risk in Clinical Research. Dr Martha J Wrigley R&D Manager Senior Visiting Fellow University of Surrey

Managing Risk in Clinical Research. Dr Martha J Wrigley R&D Manager Senior Visiting Fellow University of Surrey Managing Risk in Clinical Research Dr Martha J Wrigley R&D Manager Senior Visiting Fellow University of Surrey Aim of the session To explore the risks associated with clinical research and understand how

More information

Sample Agreement for External Responsible Officer Services

Sample Agreement for External Responsible Officer Services Sample Agreement for External Responsible Officer Services Version 1.0 May 2012 www.revalidationsupport.nhs.uk 1. Introduction This document contains a sample agreement which designated bodies in England

More information

NHS Pensions - Pension Credit Member - Consideration of entitlement for early payment of deferred benefits due to ill health (AW240(PC))

NHS Pensions - Pension Credit Member - Consideration of entitlement for early payment of deferred benefits due to ill health (AW240(PC)) NHS Pensions - Pension Credit Member - Consideration of entitlement for early payment of deferred benefits due to ill health (AW240(PC)) Before completing this form please read the notes below. We normally

More information

MENTAL CAPACITY ACT (MCA) 2005 & MCA DEPRIVATION OF LIBERTY SAFEGUARDS (DOLS) POLICY

MENTAL CAPACITY ACT (MCA) 2005 & MCA DEPRIVATION OF LIBERTY SAFEGUARDS (DOLS) POLICY Medical Director MENTAL CAPACITY ACT (MCA) 2005 & MCA DEPRIVATION OF LIBERTY SAFEGUARDS (DOLS) POLICY Reference: MDP024 Version: 1.3 This version issued: 09/03/12 Result of last review: Reissued without

More information

Shorter-form NHS Standard Contract for 2016/17. User guide

Shorter-form NHS Standard Contract for 2016/17. User guide Shorter-form NHS Standard Contract for 2016/17 User guide Shorter-form 2016/17:User guide Version number: 1 First published: March 2016 Updated: Prepared by: Document Classification: NA Team Official Publications

More information

PATIENT INFORMATION SHEET

PATIENT INFORMATION SHEET PATIENT INFORMATION SHEET Surgical and large bore pleural procedures in Malignant pleural Mesothelioma And Radiotherapy Trial (SMART trial) Stoke Mandeville Hospital Mandeville Road Aylesbury Buckinghamshire

More information

RESEARCH GOVERNANCE POLICY

RESEARCH GOVERNANCE POLICY RESEARCH GOVERNANCE POLICY Policy Title Version: Approved by: Date of approval: 29 June 2015 Policy supersedes: Lead Board Director: Policy Lead (and author if different): Name of responsible committee/group:

More information

Standard Operating Procedure on Training Requirements for staff participating in CTIMPs Sponsored by UCL

Standard Operating Procedure on Training Requirements for staff participating in CTIMPs Sponsored by UCL Page 1 of 10 Standard Operating Procedure on Training Requirements for staff participating in CTIMPs Sponsored by UCL SOP ID Number: Effective Date:01/08/2012 Version Number & Date of Authorisation: V02,

More information

Uncontrolled When Printed. Version 1.1. Consultation Group: Approver: Co-ordinators: Grampian Medicines Management Group. Deputy Director of Pharmacy

Uncontrolled When Printed. Version 1.1. Consultation Group: Approver: Co-ordinators: Grampian Medicines Management Group. Deputy Director of Pharmacy NHS Grampian Staff Policy For Patients To Receive Aspects Of Their Treatment Through Private Healthcare Providers (Co-Payments) In Respect Of Medicines Co-ordinators: Deputy Director of Pharmacy Consultation

More information

APIL SCOTLAND CLINICAL NEGLIGENCE COMPETENCY STANDARD - PERSONAL CANDIDATE RECORD SHEET (to be kept internally at the firm not for submission)

APIL SCOTLAND CLINICAL NEGLIGENCE COMPETENCY STANDARD - PERSONAL CANDIDATE RECORD SHEET (to be kept internally at the firm not for submission) APIL SCOTLAND CLINICAL NEGLIGENCE COMPETENCY STANDARD - PERSONAL CANDIDATE RECORD SHEET (to be kept internally at the firm not for submission) This record sheet sets out the additional competency standards,

More information

Supporting information for appraisal and revalidation

Supporting information for appraisal and revalidation Supporting information for appraisal and revalidation During their annual appraisals, doctors will use supporting information to demonstrate that they are continuing to meet the principles and values set

More information

Attributing the costs of health and social care Research and Development (AcoRD)

Attributing the costs of health and social care Research and Development (AcoRD) Attributing the costs of health and social care Research and Development (AcoRD) Page 1 of 8 Contents Contents. 2 Purpose.. 3 Background. 3 Basic Principles.. 4 Commercial Contract Studies.. 4 Non-commercial

More information

Record keeping. Guidance for nurses and midwives

Record keeping. Guidance for nurses and midwives Record keeping Guidance for nurses and midwives 1 We are the nursing and midwifery regulator for England, Wales, Scotland, Northern Ireland and the Islands. We exist to safeguard the health and wellbeing

More information

The people needed to complete the costs for a funding application are:

The people needed to complete the costs for a funding application are: Research Design Service London Guide to costing grant applications The people needed to complete the costs for a funding application are: The chief investigators and or senior researchers Your local Trust,

More information

PRISM: PROGESTERONE IN EARLY PREGNANCY BLEEDING

PRISM: PROGESTERONE IN EARLY PREGNANCY BLEEDING Participant Information Sheet PRISM: PROGESTERONE IN EARLY PREGNANCY BLEEDING TRIAL CO-ORDINATOR Name: Adam Devall Telephone: 0121 623 6835 Email: prism@trials.bham.ac.uk This study is being funded by

More information

PARTICIPANT INFORMATION SHEET FEASIBILITY TRIAL Final Version 1.1:

PARTICIPANT INFORMATION SHEET FEASIBILITY TRIAL Final Version 1.1: PARTICIPANT INFORMATION SHEET FEASIBILITY TRIAL Final Version 1.1: 10.10.13 Title of Study: FRESH: Facilitating Return to work through Early Specialist Health-based interventions. (Working After Brain

More information

STANDARD OPERATING PROCEDURE FOR RESEARCH. Management of Essential Documents and Trial Folders

STANDARD OPERATING PROCEDURE FOR RESEARCH. Management of Essential Documents and Trial Folders STANDARD OPERATING PROCEDURE FOR RESEARCH Management of Essential Documents and Trial Folders Author Linda Ward Author s Job Title QA Coordinator Division Department Version number 2 Ref SOP/CLN/001/2

More information

Supporting information for appraisal and revalidation

Supporting information for appraisal and revalidation Supporting information for appraisal and revalidation During their annual appraisals, doctors will use supporting information to demonstrate that they are continuing to meet the principles and values

More information

THE IPSWICH HOSPITAL NHS TRUST. Healthcare Governance Committee. TERMS OF REFERENCE Version 10.0

THE IPSWICH HOSPITAL NHS TRUST. Healthcare Governance Committee. TERMS OF REFERENCE Version 10.0 THE IPSWICH HOSPITAL NHS TRUST Healthcare Governance Committee TERMS OF REFERENCE Version 10.0 Purpose: For use by: This document is compliant with /supports compliance with: To provide Terms of Reference

More information

About public outpatient services

About public outpatient services About public outpatient services Frequently asked questions What are outpatient services? Victoria s public hospitals provide services to patients needing specialist medical, paediatric, obstetric or surgical

More information

Royal College of Obstetricians and Gynaecologists. Faculty of Sexual and Reproductive Healthcare

Royal College of Obstetricians and Gynaecologists. Faculty of Sexual and Reproductive Healthcare Royal College of Obstetricians and Gynaecologists Faculty of Sexual and Reproductive Healthcare Supporting Information for Appraisal and Revalidation: Guidance for Obstetrics and Gynaecology and / or Sexual

More information

AIR. Ankle Injury Rehabilitation. Chief Investigator: Dr Rebecca Kearney PATIENT INFORMATION SHEET

AIR. Ankle Injury Rehabilitation. Chief Investigator: Dr Rebecca Kearney PATIENT INFORMATION SHEET AIR Ankle Injury Rehabilitation Chief Investigator: Dr Rebecca Kearney PATIENT INFORMATION SHEET We would like to invite you to take part in our research study, investigating two different treatments for

More information

Patient Information Leaflet: Part 1 select-d

Patient Information Leaflet: Part 1 select-d Patient Information Leaflet: Part 1 select-d Anticoagulation Therapy in SELECTeD Cancer Patients at Risk of Recurrence of Venous Thromboembolism Introduction This

More information

Workstream 4: Trial Management and Monitoring: B) Summary of Trial Management Systems (TMS)

Workstream 4: Trial Management and Monitoring: B) Summary of Trial Management Systems (TMS) Trial Management Workstream 4: Trial Management and Monitoring: B) Summary of Trial Management Systems (TMS) Trial management is the process of ensuring that a trial is run effectively and within budget.

More information

The Practicalities of Data Standards

The Practicalities of Data Standards The Practicalities of Data Standards Provided by Catherine Carpenter-Clawson, Research Network Manager For EDGE User Conference 2014 17 th March 2014 Contents Example 1: Local challenges with study arm

More information

Improving end-of-life care professional development for physicians

Improving end-of-life care professional development for physicians Improving end-of-life care professional development for physicians The summary and recommendations presented here are for clinicians, and are taken from Improving end-of-life care: professional development

More information

HOW WE USE YOUR PERSONAL INFORMATION

HOW WE USE YOUR PERSONAL INFORMATION HOW WE USE YOUR PERSONAL INFORMATION Information Leaflet Your Health. Our Priority. Page 2 of 9 Introduction This Leaflet explains why the NHS collects information about you and how it is used, your right

More information

A Guide to Clinical Trials

A Guide to Clinical Trials A Guide to Clinical Trials For young people with cancer and their parents Children s Cancer and Leukaemia Group www.cclg.org.uk Original booklet produced in conjunction with the CCLG Patient Advocacy Committee.

More information

Root Cause Analysis Investigation Tools. Concise RCA investigation report examples

Root Cause Analysis Investigation Tools. Concise RCA investigation report examples Root Cause Analysis Investigation Tools Concise RCA investigation report examples www.npsa.nhs.uk/nrls Acute service example Mental health example Ambulance service example Primary care example Acute service

More information

A Guide to Pharmacy Documentation For Clinical Trials

A Guide to Pharmacy Documentation For Clinical Trials A Guide to Pharmacy Documentation For Clinical Trials Roy Sinclair Clinical Trials Pharmacist St. George s Hospital (to Sep 2007) Lecturer Kingston University January 2008 A Guide to Pharmacy Documentation

More information

CLINICAL STUDIES GUIDELINE FUNDING APPLICATION

CLINICAL STUDIES GUIDELINE FUNDING APPLICATION CLINICAL STUDIES GUIDELINE FUNDING APPLICATION Applications for Full Study Funding (over 30,000)... 2 Applications for Pilot / Feasibility Funding (Under 30,000)... 2 Applications for Virements (movement

More information

Process for advising on the feasibility of implementing a patient access scheme

Process for advising on the feasibility of implementing a patient access scheme Process for advising on the feasibility of implementing a patient access scheme INTERIM September 2009 Patient Access Schemes Liaison Unit at NICE P001_PASLU_Process_Guide_V1.3 Page 1 of 21 Contents (to

More information

Data Collection & Reporting for the Major Trauma Best Practice Tariff. Support Document for Data Coordinators at Major Trauma Centres

Data Collection & Reporting for the Major Trauma Best Practice Tariff. Support Document for Data Coordinators at Major Trauma Centres Data Collection & Reporting for the Major Trauma Best Practice Tariff Support Document for Data Coordinators at Major Trauma Centres Major Trauma Best Practice Tariff: Completing the TARN Submission and

More information

Raising Concerns or Complaints about NHS services

Raising Concerns or Complaints about NHS services Raising Concerns or Complaints about NHS services Raising concerns and complaints A step by step guide Raising concerns and complaints Questions to ask yourself: 1. What am I concerned or dissatisfied

More information

MENTAL CAPACITY ACT (MCA) 2005 & MCA DEPRIVATION OF LIBERTY SAFEGUARDS (DOLS) POLICY

MENTAL CAPACITY ACT (MCA) 2005 & MCA DEPRIVATION OF LIBERTY SAFEGUARDS (DOLS) POLICY Directorate of Performance Assurance MENTAL CAPACITY ACT (MCA) 2005 & MCA DEPRIVATION OF LIBERTY SAFEGUARDS (DOLS) POLICY Reference: DCP098 Version: 1.4 This version issued: 21/04/15 Result of last review:

More information

Guidance for registered pharmacies providing pharmacy services at a distance, including on the internet

Guidance for registered pharmacies providing pharmacy services at a distance, including on the internet Guidance for registered pharmacies providing pharmacy services at a distance, including on the internet April 2015 The General Pharmaceutical Council is the regulator for pharmacists, pharmacy technicians

More information

GUIDANCE FOR THE NOTIFICATION OF SERIOUS BREACHES OF GCP OR THE TRIAL PROTOCOL

GUIDANCE FOR THE NOTIFICATION OF SERIOUS BREACHES OF GCP OR THE TRIAL PROTOCOL GUIDANCE FOR THE NOTIFICATION OF SERIOUS BREACHES OF GCP OR THE TRIAL PROTOCOL Table of Contents A. Legal requirement... 1 B. Purpose of the requirement... 1 C. Purpose of this guidance... 2 D. Arrangements

More information

The CRT fidelity survey. Danielle Lamb Deputy Programme Manager CORE study

The CRT fidelity survey. Danielle Lamb Deputy Programme Manager CORE study The CRT fidelity survey Danielle Lamb Deputy Programme Manager CORE study D.Lamb@UCL.ac.uk Outline Aims of CORE Development of a fidelity measure Challenges and resources Concept mapping The fidelity scale

More information